A realist review of medication optimisation of community dwelling service users with serious mental illness.

导出 OA

翻译打印收藏纠错

作者： Jo,Howe ^[1] ; Maura,MacPhee ^[2] ; Claire,Duddy ^[3] ; Hafsah,Habib ^[4] ; Geoff,Wong ^[3] ; Simon,Jacklin ^[5] ; Sheri,Oduola ^[6] ; Rachel,Upthegrove ^[7] ; Max,Carlish ^[8] ; Katherine,Allen ^[8] ; Emma,Patterson ^[8] ; Ian,Maidment ^[9]

作者单位： Pharmacy School, College of Health and Life Sciences, Aston University, Birmingham, UK j.howe1@aston.ac.uk. ^[1] School of Nursing, The University of British Columbia, Vancouver, British Columbia, Canada. ^[2] Primary Care Health Sciences, University of Oxford, Oxford, UK. ^[3] Pharmacy School, Aston University College of Health and Life Sciences, Birmingham, UK. ^[4] School of Pharmacy and Bioengineering, Keele University, Keele, UK. ^[5] School of Health Sciences, University of East Anglia, Norwich, UK. ^[6] Institute for Mental Health, University of Birmingham, Birmingham, UK.;Birmingham Early Intervention Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK. ^[7] Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK. ^[8] Pharmacy School, College of Health and Life Sciences, Aston University, Birmingham, UK. ^[9]

关键词 compliance medication safety mental health patient-centred care shared decision making

主题词人类(Humans);精神障碍(Mental Disorders);抗精神病药(Antipsychotic Agents);独立生活(Independent Living);社区精神卫生服务(Community Mental Health Services)

DOI 10.1136/bmjqs-2023-016615

PMID 38071586

发布时间 2025-01-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交